Predicting prostate cancer risk through incorporation of prostate cancer gene 3. - Wikidata - awgldk - TriplyDB

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

http://www.wikidata.org/entity/Q34809531

about

Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.The novel prostate cancer antigen 3 (PCA3) biomarker.Novel diagnostic biomarkers for prostate cancer.Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer.Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.Prostate cancer risk prediction in a urology clinic in Mexico.The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.Updating risk prediction tools: a case study in prostate cancer.Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator Biomarkers in prostate cancer surveillance and screening: past, present, and future.Making the case for molecular staging of malignant pleural mesothelioma.Optimising repeat prostate biopsy decisions and procedures.Risk stratification in prostate cancer screening.PCA3 in the detection and management of early prostate cancer.Risk-based prostate cancer screening: who and how?Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancer.Prostate cancer: measuring PSA.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.Current biomarkers for diagnosing of prostate cancer.The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.External validation of a PCA-3-based nomogram for predicting prostate cancer and high-grade cancer on initial prostate biopsy.Comparison of approaches for incorporating new information into existing risk prediction models.Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer.The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort.PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy.Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.

P2860

Q27027085-5AA057D0-11D2-4C86-B2D4-4ED201232A59 Q33672510-5D84AE8D-E9A1-4F97-8A14-992A4E7D5310 Q33751970-8E6F7E81-09F3-49A2-8039-232B8B6BC198 Q33922385-23A823A8-13A7-4B77-AE01-74DF056CC31D Q34156075-455AAD00-72FB-4766-A8A7-3387882EC292 Q34231678-1281F963-723A-487C-A3A3-B54D31DE89C1 Q35251546-F8F189A8-F555-4A1F-AC38-63E34F490CB3 Q35771276-30F2900B-5AFA-4990-990F-F497441C2930 Q35996067-F21A43D6-B6A1-426E-BEE2-5EFE6520889B Q36185925-BD9792E8-5F6B-47F7-AFB7-4EA3E05F1A75 Q36739758-AAD14300-D190-4AD6-876E-5E81BE1576B2 Q37025404-CBE02E47-4364-46E2-9918-140F324BC2F2 Q37279076-300D63CB-76F7-4519-A60E-4C94F7C20EF0 Q37300931-41A4D72E-C97B-4409-820B-FF7A67190A1C Q37613240-CA31258E-D7E0-404F-9919-D7A777C6AA6E Q37970859-FCF735FE-ABAE-46A3-923A-A39A62E23F17 Q38068114-DF0F9A69-C6E8-4104-AFBB-ABF4A374B914 Q38090552-770E306B-12A2-4692-916C-5839A1ECE3F1 Q38093463-C972B616-B213-4114-8449-678B70FCD8B1 Q38144712-6E723152-95D7-4DC0-8848-0300415D0404 Q38191938-C48443C1-701D-42FF-9F91-6868C2365EF8 Q38210857-77455B9A-A303-491E-B941-3704E313214F Q38211603-6DACD58E-E838-4622-9553-78C1C323403A Q38268839-FF13C727-C5C0-44AA-9939-C9361D25FC68 Q38584370-D03A458E-2A52-42D4-8077-C018A038D28F Q38741968-560623DA-E132-47EB-BEDC-01E3F96982F6 Q38838706-7544BC0F-A312-4701-8666-CE2FDF884BC5 Q39108831-23CE02A6-061C-4D9E-8301-AAA28F9ACA8E Q40005109-4B64F499-B867-4427-BA55-7AE71E806D10 Q40037072-818B8E8A-B700-425F-9DAB-A3B27C3831D3 Q40216437-FD56D68A-B143-4B68-97F0-3EC9993BA441 Q40314717-51669CEC-BACE-4F88-BBB5-65EF8BE325C7 Q42663818-9D872A1F-35D2-4DE8-9E9F-C26E8EF769B1 Q42932905-F95E1234-9297-4AB3-BAF6-6CC69135486D Q48252578-243EC16D-7035-4D78-94D7-D89AFA640C99 Q55401042-A0BD2630-97A0-44D6-9BFB-7AA4BF156CA5

P2860

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

http://www.wikidata.org/entity/Q34809531

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@ast

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@en

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@nl

type

label

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@ast

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@en

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@nl

prefLabel

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@ast

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@en

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@nl

P1433

Q34809531-6AF46710-1FC7-4661-93BC-90D1B315BB4E

P1476

Q34809531-976CE87B-036B-487A-8352-1AB1241264EE

P2093

Q34809531-004F4A39-4C08-4C8A-9A00-31856AC73E71

Q34809531-09A34037-54F0-4EA2-92CA-7280E52565C2

Q34809531-3D146E98-62FB-4301-A63D-EE496550094C

Q34809531-3F0B03A5-C97E-4072-B3C4-327E808C916D

Q34809531-622F29B6-3624-4EB8-9A31-97FCEA180145

Q34809531-8CA19FE3-0AB9-4E15-A336-1CEEEE8D2532

Q34809531-8F27F5E2-CEC5-4DCC-B3CA-A4999E2836F0

Q34809531-E09EFA9B-4587-42CB-964C-94E14BBE1687

Q34809531-E83C88C1-D09F-442A-ADBF-5F32DE4863F8

P304

Q34809531-78BDF523-1862-4B20-BF1E-037B35D6FC93

P31

Q34809531-86BF205F-DFFF-45C2-9550-837A9DE1ED36

P356

Q34809531-EC7B6C23-D2EC-40DB-9525-FF2CB67C524F

P407

Q34809531-2853FF77-67E1-44F5-B76F-609FED0862F6

P433

Q34809531-E224D9E0-4B08-453C-8093-F05E8C90E9BE

P478

Q34809531-24121EC6-F174-407F-B02E-5641BC1B7D69

P50

Q34809531-55413CEC-6631-4F52-81F9-06CACAADA510

P577

Q34809531-7AD9B194-EC94-4BE0-B25C-918E28B8EC7A

P698

Q34809531-702D1391-2001-40CF-922C-CAE4D0896B18

P356

J.JURO.2008.06.038

P1433

The Journal of Urology

P1476

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

@en

P2093

Amy Blase

http://www.w3.org/2001/XMLSchema#string

Brad H Pollock

http://www.w3.org/2001/XMLSchema#string

Cathy Tangen

http://www.w3.org/2001/XMLSchema#string

Dipen Parekh

http://www.w3.org/2001/XMLSchema#string

Harry Rittenhouse

http://www.w3.org/2001/XMLSchema#string

Ian Thompson

http://www.w3.org/2001/XMLSchema#string

Jack Groskopf

http://www.w3.org/2001/XMLSchema#string

John R Day

http://www.w3.org/2001/XMLSchema#string

Robin J Leach

http://www.w3.org/2001/XMLSchema#string

P304

1303-8; discussion 1308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2008.06.038

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18707724

http://www.w3.org/2001/XMLSchema#string